Growth Metrics

Integra Lifesciences Holdings (IART) Free Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.28%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 22.80%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -27.72%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -0.27%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 77.20%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -20.37%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.32%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn -33.98%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -33.98%
Dec 31, 2025 -27.57%
Sep 30, 2025 -24.21%
Jun 30, 2025 -29.99%
Mar 31, 2025 -46.55%
Dec 31, 2024 -20.36%
Sep 30, 2024 -27.95%
Jun 30, 2024 -49.82%
Mar 31, 2024 -83.29%
Dec 31, 2023 -21.90%
Sep 30, 2023 -39.85%
Jun 30, 2023 -21.08%
Mar 31, 2023 42.59%
Dec 31, 2022 1.90%
Sep 30, 2022 5.31%
Jun 30, 2022 22.75%
Mar 31, 2022 37.75%
Dec 31, 2021 35.02%
Sep 30, 2021 6.45%
Jun 30, 2021 73.49%
Mar 31, 2021 33.64%
Dec 31, 2020 228.48%
Sep 30, 2020 18.88%
Jun 30, 2020 17.29%
Mar 31, 2020 -39.80%
Dec 31, 2019 87.28%
Sep 30, 2019 8.37%
Jun 30, 2019 1.16%
Mar 31, 2019 -1.77%
Dec 31, 2018 10.68%
Sep 30, 2018 63.76%
Jun 30, 2018 -19.06%
Mar 31, 2018 -0.18%
Dec 31, 2017 32.53%
Sep 30, 2017 14.94%
Jun 30, 2017 31.74%
Mar 31, 2017 525.82%
Dec 31, 2016 -60.42%
Sep 30, 2016 31.35%
Jun 30, 2016 68.51%
Mar 31, 2016 88.53%
Dec 31, 2015 34.75%
Sep 30, 2015 20.27%
Jun 30, 2015 65.79%
Mar 31, 2015 6.27%
Dec 31, 2014 -32.44%
Sep 30, 2014 28.76%
Jun 30, 2014 -26.06%
Mar 31, 2014 -26.10%
Dec 31, 2013 -12.23%
Sep 30, 2013 -7.85%
Jun 30, 2013 -101.75%
Mar 31, 2013 -27.82%
Dec 31, 2012 -40.70%
Sep 30, 2012 -28.79%